ARS Pharmaceuticals, Inc.
SPRY
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Roanna Ruiz | Leerink Partners | 9.28 $ | 26 $ | 16.72 % | 10/03/2026 |
| Kyle Bauser | Roth Capital | 8.415 $ | 30 $ | 21.59 % | 04/11/2025 |
| Josh Schimmer | Cantor Fitzgerald | 14.24 $ | 30 $ | 15.76 % | 19/08/2024 |
| Strong Buy | Raymond James | 10.85 $ | 22 $ | 11.15 % | 12/08/2024 |
| Ryan Deschner | Raymond James | 10.4 $ | 18 $ | 7.60 % | 25/07/2024 |
| Roanna Ruiz | Leerink Partners | 8.65 $ | 18 $ | 9.35 % | 05/03/2024 |